Back to search

Denmark· DK-28107181324

Nobilis Multriva REOm

A lintujen reovirus product, registered in Denmark by Intervet International B.V.. The same ATC class is registered in 2 of our 19 countries.

ATC QI01AA04

Checked against Danish Medicines Agency (Denmark) on

Informational only — not a medical device.

SOURCE REGISTER · DKDanish Medicines Agency (Denmark)normalisedNobilis Multriva REOmATCQI01AA04REGISTER NO.DK-28107181324PACKS LISTED1CHECKEDSeptember 30, 2026

Where it is registered

Nobilis is registered in 2 of 19 countries.

Countries holding a registration under ATC QI01AA04 (lintujen reovirus), each read from that country’s own register.

  • This record: Denmark, from Danish Medicines Agency (Denmark)
  • 1 of them publish a price we can compare per daily dose

Nobilis · ATC QI01AA04

2 / 19 countries

  • Denmark
  • Finlandprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

The record

At a glance

Danish Medicines Agency (Denmark)
Manufacturer
Intervet International B.V.
Country
Denmark (DK)
ATC code
QI01AA04
ATC class
lintujen reovirus
Reimbursed
Not published by this register
Source register
Danish Medicines Agency (Denmark)
Last checked
September 30, 2026

Packs & prices · 1

  • dk_varenummer
    28107181324

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Same class

Other records under QI01AA04

Lintujen reovirus, as other registers publish it.

All Nobilis products

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Danish Medicines Agency (Denmark). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/51463387-21c7-4829-887a-448fe76708cc
GET /v1/drugs/51463387-21c7-4829-887a-448fe76708cc?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "form": "injektionsvæske, emulsion",
  "source": "dkma",
  "strength": "10926",
  "auth_role": "MOD",
  "dk_drugid": "28107181324",
  "substance": null,
  "auth_procedure": "Central",
  "in_medicinpriser": true,
  "registration_date_serial": "45715"
}

See everything about Nobilis.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.